Fuller & Thaler Asset Management’s DermTech, Inc. Common Stock DMTK Stock Holding History

Fuller & Thaler Asset Management’s Portfolio DMTK Stock Details DMTK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-67,049	Closed	-$371K	–	508
2022 Q2	$371K	Buy	67,049 +450	+0.7%	+$3.69K	﹤0.01%	417
2022 Q1	$978K	Buy	66,599 +325	+0.5%	+$4.35K	0.01%	404
2021 Q4	$1.05M	Buy	66,274 +325	+0.5%	+$7.8K	0.01%	399
2021 Q3	$2.12M	Sell	65,949 -300	-0.5%	-$10.5K	0.01%	349
2021 Q2	$2.75M	Sell	66,249 -1,630	-2%	-$67K	0.02%	318
2021 Q1	$3.45M	Sell	67,879 -6,260	-8%	-$327K	0.02%	281
2020 Q4	$2.4M	Sell	74,139 -3,980	-5%	-$56.4K	0.02%	304
2020 Q3	$934K	Buy	+78,119	New	+$905K	0.01%	349

Other funds holding DMTK

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AIA

Avalon Investment & Advisory Houston, Texas $3.65B AUM 0.47% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fuller & Thaler Asset Management's DMTK Position: Q3 2022 in Review

Fuller & Thaler Asset Management sold out of DermTech, Inc. Common Stock (DMTK) in Q3 2022, closing a stake of 67,049 shares — an estimated $371K sold.

Fuller & Thaler Asset Management first reported a position in DMTK in Q3 2020 and held it in 8 quarters. The position peaked at $3.45M in Q1 2021. 127 funds tracked by Wall St. Rank hold DMTK as of Q3 2022.

Fuller & Thaler Asset Management reported no remaining DermTech, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Fuller & Thaler Asset Management sold 67,049 DermTech, Inc. Common Stock shares in Q3 2022, an estimated $371K.
Fuller & Thaler Asset Management first reported a position in DermTech, Inc. Common Stock in Q3 2020 and held it in 8 quarters.
Fuller & Thaler Asset Management's DermTech, Inc. Common Stock position peaked at $3.45M in Q1 2021.
127 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q3 2022.

Based on Fuller & Thaler Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.